Upload
eurocto
View
72
Download
4
Embed Size (px)
Citation preview
Antegrade dissection re-entry step
by step
EuroCTO Club
September 30, 2016
Emmanouil S. Brilakis, MD, PhD
Minneapolis Heart Institute
Adj. Professor of Medicine, UT Southwestern
14.00-14.30
ES Brilakis: Disclosures
Consulting/speaker honoraria: Abbott
Vascular, Asahi, Cardinal Health, CTI,
Elsevier, GE Healthcare, St Jude
Medical
Employment (spouse): Medtronic
Grants: InfraRedx, Boston Scientific
VA - I01-CX000787-01
VA CSP#571 – DIVA
CTO dissection/re-entry
strategies
Antegrade Retrograde
Dissection
Re-entry
Dissection
Re-entry
Knuckle wire
CrossBoss
•STAR
•Contrast-guided STAR
•mini-STAR
•LAST
•Stingray
Knuckle wire
CART
Reverse CART
Michael et al
Circ Intv 2012
1 2
34
Extensive dissection/re-entry long-term outcomes
Brilakis, Grantham, Rinfret, Wyman, Burke, Karmpaliotis, Lembo, Pershad,
Kandzari, Buller, De Martini, Lombardi, Thompson. JACC Intv 2012
Antegrade dissection/re-entry: WHEN?
Nagoya Heart Center
Asian-Pacific CTO Club Algorithm
www.crossbossfirst.org
Ratchet Handle for FAST-Spin Technique
Atraumatic 1 mm Distal Tip
CrossBoss Knuckle wire
Polymer-jacketed
guidewire
Dissection
How to form a knuckle
Wire: Fielder XT – Fighter -Pilot 200
Tip: umbrella handle or no shaping
Movement: PUSH (hard!)
Do NOT turn
Step 1: get to proximal cap
Step 2: torquer positioning
2 fingerbreadths
Step 3: SPIN (fast!)
CrossBoss does not advance: ↑ guide catheter support,
Guideliner, knuckle wire, use stiff wire
Any direction is fine
Step 4: Assess!
A
B
C
BridgePoint Procedure
Step 5A: wire + stent
A
Case 1
RCA
CTO due
to ISR
ASSESSMENT
Target vessel: RCA
Proximal cap: clear
Length: ~50 mm
Distal vessel: good landing zone before
the bifurcation
Collaterals: Septal, epicardial
PLAN
1. ADR (Crossboss)
2. Retrograde
CrossBoss
with Sion
Blue
Wire inside
CrossBoss
Crossing
with
CrossBoss
CrossBoss
confirmed
in true
lumen
Confirmed
in RAO
Cranial
Final result
Procedure time: 65 min
Fluoroscopy time: 14.6 min
AK dose: 0.348 Gray
Contrast: 200 mL
N=31 CTOs - Procedural success: 90%
N=6
Procedural success: 83%
Step 5B: Re-enter
B
1) Use Stingray LP
2) Aspirate first
3) “stick and swap” (especially in
diffusely diseased vessels)
4) Orthogonal view for re-entry (good
balloon preparation)
5) Minimize area of dissection (using
CrossBoss)
6) select optimal re-entry location
(horizontal part of RCA)
Facilitating Stingray Re-entry
Stick and Swap – 1
Stingray wire –
or Gaia 2nd/3rd
Stiff wire cannot track into diffusely diseased vessel
Stingray
wire
removed
Stick and Swap – 2
Polymer
jacketed wire –
Pilot 200 -
Gladius
Polymer-jacketed wire tracks distal vessel
Stick and Swap – 3
Stingray Re-entry
Orthogonal view
railroad tracks
1) Aspirate through Stingray balloon
2) STRAW
3) Double blind stick and swap
4) Bobsled
5) Retrograde
What to do for subintimal hematoma
STRAW: Subintimal TRAnscatheter Withdrawal
Brilakis ES. Manual of coronary CTO interventions. Elsevier 2013
LCX CTO
ASSESSMENT
Target vessel: LCX
Stump: Tapered
Length: ~20 mm
Distal vessel: Bifurcation
Collaterals: Ipsilateral
J-CTO score: 2
Stump: 0
Length: 0
Calcification: 1
Tortuosity: 1
Previous attempt: 0
CrossBoss
Some
progress
Crossed
Confirmed
Corsair
with a Sion
Blue
Stingray to
open OM
1st
Re-entry
with “stick
and swap”
Stingray
with Pilot
200
Predilation
Kissing
balloons
3.0x38 mm
DES
Postdilation
Final result
Procedure time: 73 min
Fluoroscopy time: 29.7 min
AK dose: 1.608 Gray
Contrast: 100 mL
Step 5C: Redirect
C
RCA
CTO
Case 2
RCA
CTO
Case 2
CrossBoss
into side
branches
Knuckle
for
advancing
Case 2
In distal
cap now
Case 2
Stingray
Case 2
Are we in?
Case 2
Case 2
Restick
Case 2
IVUS 2
Case 2
RCA CTO
Retrograde
failed
Proximal
cap??
Lateral
Confianza
Pro 12
“scratch
and go”
Aka
“move the
cap”
Proximal
dissection
1.5x8 mm
anchor
Knuckle
started
Distal RCA
ISR
Wire is out!
CrossBoss
Pilot 200
Some
progress..
Getting
closer..
Going the
wrong
way…
Gaia
redirection
Gaia
redirection
Threader
1st line
2nd line
Brilakis ES. Manual of coronary CTO interventions. Elsevier 2013
Approach to “balloon uncrossable” CTO
“Balloon Uncrossable” CTO
• Inflate 1.20-1.5 mm balloon, Threader, Glider
• Rupture balloon in vessel (grenadoplasty)
• Tornus, Corsair, Finecross
• Wire “cutting”
• Guide catheter extensions
• Anchor balloon strategies
• Laser
• Rotational atherectomy
• Subintimal: external “crush” - retrograde
• Subintimal: distal anchor
combinations
3rd line
4th line
Sticking UP
Sticking
down
Swap
Confirm 1
Confirm 2
IVUS post crossing
Final
IVUS after stenting
RAO
Case 3
Hybrid CTO crossing algorithm
Brilakis, Grantham, Rinfret, Wyman, Burke, Karmpaliotis, Lembo, Pershad, Kandzari, Buller, De Martini,
Lombardi, Thompson J Am Coll Cardiol Intv 2012;5:367-379
Knuckle
started
Fielder XT
Stuck!
Carlino
Next step?
Aggressive
knuckle
Gaia 2nd
Stick down!
Stick up!
Swap
Orthogonal
view
Final
Contrast: 450 mL iodixanol
AK dose: 5.8 Gray
Fluoro time: 56.9 min
Antegrade crossing
Finecross
Pilot 200
Finecross and 1.5 mm balloon: No crossing
Subintimal wiring
2nd wire
“Subintimal” Distal Anchor
Subintimaldistal
anchor
Final result
COMPLICATIONS
STAR
After
balloon
Fielder XT
Stuck…
Parallel
wire
Crossed?
Visconti G, Focaccio A, Donahue M, Briguori C. CCI 2015;85:382–390
Spontaneous echo contrast
Visconti G, Focaccio A, Donahue M, Briguori C. CCI 2015;85:382–390
Spontaneous echo contrast
2.5 x 28 mm EES x 2
2.75 x 28 mm EES x 1
2.75 x 23 mm EES x 1ADR
Baseline
Final
Final
8-month angiographic follow-up
Patient asymptomatic
1/2012 to 6/2016
15 centers, 1,810
lesionsTechnical success: 88%
Major complications: 2.5%
•Appleton Cardiology, WI
•Baylor Heart and Vascular Hospital, TX
•Columbia University, NY
•Central Arkansas VAMC, AR
•Dallas VAMC/UTSW, TX
•Henry Ford Hospital, MI
•Massachusetts General Hospital, MA
•Medical Center of the Rockies, CO
•Minneapolis VAMC, MN
•PeaceHealth St. Joseph MC, WA
•Piedmont Heart Institute, GA
•San Diego VAMC and UCSD, CA
•St Luke’s Mid America Heart Institute, MO
•Torrance Medical Center, CA
•UPMC Medical Center, PA
49%
24%
27%
Antegrade wiring
Antegrade dissection/re-entry
Retrograde75.9%
34.6%39.9%
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
Techniques Used
Antegrade
Antegrade DR
Retrograde
Successful technique
PROspective Global REgiStry for the Study of CTO interventions
0.6% mortality, 0.9% MI
0.8% pericardiocentesis, 0.2% stroke
0.1% CABG, 0.2% re-PCI
J-CTO score and CTO PCI
approach
PROspective Global REgiStry for the
Study of CTO interventions
J-CTO score validation
Procedural time and J-CTO
score
1/2012 to 7/2014
6 centers, n=650
lesions
Christopoulos, Wyman, Alaswad, Karmpaliotis, Lombardi, Grantham, Yeh, Jaffer, Cipher, Rangan,
Christakopoulos, Kypreos, Lembo, Kandzari, Garcia, Thompson, Banerjee, Brilakis
Circ Cardiovasc Interv 2015;8:e002171
N=1313
11 US centers
ADR=458 (34.9%), ADR after exclusion of retrograde cases=248 (32.3% of 767
antegrade-only cases)
Complications 2.9 vs. 2.2% all cases, 1.5 vs. 0.6% antegrade-onlyDanek, Karatasakis, Karmpaliotis, Alaswad, Yeh, Jaffer, Patel, Bahadorani, Lombardi, Wyman, Grantham, Doing,
Moses, Kirtane, Parikh, Ali, Kalra, Kandzari, Lembo, Garcia, Rangan, Thompson, Banerjee, Brilakis.
Int J Cardiol 2016
Antegrade Dissection Re-entry
PROspective Global REgiStry for the Study of CTO interventions
89.9 87.0
93.2 91.8
70
80
90
100
Technical success Procedural success
%
ADR Non-ADR Δ=3.3%
P<0.01
89.9 87.0 93.2 91.8
70
80
90
100
Technical success Procedural success
%
ADR AWE-only
Antegrade-
only cases
All cases
Δ=5.7%
P<0.01
Δ=2.3%
P=0.23
Δ=1.5%
P=0.43
PROspective Global REgiStry for the
Study of CTO interventionsRetrograde vs. antegrade-only: in-hospital MACE
4.3
2.1
0.4
1.3
0.60.8
1.1
0.3 0.3 0.30.1 0.1
0
Com
plic
atio
n ra
te (%
)
Retrograde
Antegrade-only
p<0.001
p=0.003
p=0.999
p=0.039
P=0.314
p=0.167
UK Hybrid CTO registry
7 centers
2012-2014
1,156 pts
30-day MACE: 1.6%
Martinez-Rumayor et
al. JACC Intv 2012
How CTO
equipment can
help in non-CTO
cases!
ADR gives you (safe) options
Options are good for life and
CTO PCI!
hence…
ADR is good!!!
1.Subintimal dissection/re-entry
techniques have revolutionized CTO
PCI (success + efficiency) – critical
part of the hybrid algorithm
2.ADR safer than retrograde
3.No increased risk for restenosis
Conclusions